Invest with us in New S-Pharma mRNA vaccine R&D factory and become Shareholder
- S-Pharma London U.K. - Investment in Biopharmaceutical Research and development (R&D) Company and activities that focus on the innovation of new products.
- S-Pharma R&D for mRNA vaccine and smart medicines. Discovering, developing and providing different branche of vaccines and medicines.
- A New Approach to Medicine: mRNA medicines take advantage of normal biological processes to express proteins and create a desired therapeutic effect.
- This enables the potential treatment of a broad spectrum of diseases, many of which cannot be addressed with current technologies.
- Therapeutic areas:
Infectious Diseases, Immuno-Oncology. Cardiovascular Diseases. Autoimmune Diseases. Rare Diseases
- The development is due to complete in Q4 2022/Q2 2023